A. O. Smith Corp (NYSE:AOS) – Analysts at Oppenheimer issued their Q1 2019 earnings per share (EPS) estimates for shares of A. O. Smith in a research note issued on Tuesday, January 29th, according to Zacks Investment Research. Oppenheimer analyst B. Blair expects that the industrial products company will post earnings per share of $0.55 for the quarter. Oppenheimer currently has a “Hold” rating on the stock.

Expedia Group Inc (NASDAQ:EXPE) – Equities researchers at Oppenheimer increased their Q4 2018 earnings estimates for shares of Expedia Group in a report issued on Tuesday, January 29th, according to Zacks Investment Research. Oppenheimer analyst J. Kelly now anticipates that the online travel company will post earnings of $0.98 per share for the quarter, up from their previous forecast of $0.87. Oppenheimer also issued estimates for Expedia Group’s Q1 2019 earnings at ($0.58) EPS, FY2019 earnings at $5.45 EPS and FY2020 earnings at $6.38 EPS.

Danaos Co. (NYSE:DAC) – Equities researchers at Jefferies Financial Group issued their Q1 2019 earnings per share estimates for Danaos in a research report issued on Wednesday, February 20th. Jefferies Financial Group analyst R. Giveans anticipates that the shipping company will post earnings of $0.16 per share for the quarter. Jefferies Financial Group also issued estimates for Danaos’ Q2 2019 earnings at $0.15 EPS, Q3 2019 earnings at $0.14 EPS, Q4 2019 earnings at $0.12 EPS, FY2019 earnings at $0.57 EPS and FY2020 earnings at $0.59 EPS.

RMR Group Inc (NASDAQ:RMR) – Equities research analysts at B. Riley decreased their FY2020 earnings estimates for shares of RMR Group in a research note issued on Tuesday, January 29th, Zacks Investment Research reports. B. Riley analyst B. Maher now expects that the financial services provider will earn $2.40 per share for the year, down from their prior estimate of $2.51. B. Riley has a “Buy” rating and a $89.00 price target on the stock.

Eastman Chemical (NYSE:EMN) – Stock analysts at Jefferies Financial Group increased their Q1 2019 earnings per share (EPS) estimates for shares of Eastman Chemical in a note issued to investors on Monday, February 4th, according to Zacks Investment Research. Jefferies Financial Group analyst L. Alexander now anticipates that the basic materials company will post earnings of $2.03 per share for the quarter, up from their prior forecast of $1.33. Jefferies Financial Group currently has a “Buy” rating and a $91.00 target price on the stock. Jefferies Financial Group also issued estimates for Eastman Chemical’s Q2 2019 earnings at $2.42 EPS and Q3 2019 earnings at $2.52 EPS.

Cheesecake Factory Inc (NASDAQ:CAKE) – Investment analysts at Piper Jaffray Companies cut their Q1 2019 EPS estimates for shares of Cheesecake Factory in a research report issued on Wednesday, February 20th. Piper Jaffray Companies analyst N. Regan now anticipates that the restaurant operator will earn $0.59 per share for the quarter, down from their prior estimate of $0.62. Piper Jaffray Companies also issued estimates for Cheesecake Factory’s Q2 2019 earnings at $0.79 EPS, Q3 2019 earnings at $0.61 EPS, Q4 2019 earnings at $0.64 EPS and FY2019 earnings at $2.64 EPS.

Fairfax Financial Holdings Ltd Subordinate Voting Shares (TSE:FFH) – Equities research analysts at Cormark raised their Q1 2019 earnings per share (EPS) estimates for Fairfax Financial Holdings Ltd Subordinate Voting Shares in a report issued on Tuesday, February 19th. Cormark analyst J. Fenwick now forecasts that the company will earn $16.47 per share for the quarter, up from their previous forecast of $14.04. Cormark also issued estimates for Fairfax Financial Holdings Ltd Subordinate Voting Shares’ Q2 2019 earnings at $17.65 EPS, Q3 2019 earnings at $18.39 EPS, Q4 2019 earnings at $18.65 EPS and FY2019 earnings at $71.17 EPS.

SAGE Therapeutics Inc (NASDAQ:SAGE) – Stock analysts at SunTrust Banks lifted their Q1 2019 earnings per share (EPS) estimates for shares of SAGE Therapeutics in a report issued on Tuesday, February 19th. SunTrust Banks analyst J. Lee now forecasts that the biopharmaceutical company will earn ($2.66) per share for the quarter, up from their prior forecast of ($2.83). SunTrust Banks also issued estimates for SAGE Therapeutics’ Q2 2019 earnings at ($2.79) EPS, Q3 2019 earnings at ($2.81) EPS, Q4 2019 earnings at ($2.94) EPS, FY2019 earnings at ($10.89) EPS, FY2020 earnings at ($9.74) EPS, FY2021 earnings at ($5.19) EPS, FY2022 earnings at $1.33 EPS and FY2023 earnings at $12.84 EPS.

February 22 was a positive day for Atlantic Power Corporation (ATP:CA) as its stock finished the day having gained 6.41% to hit a price of $3.65 a share. The company reached a market cap of 395.45 million and has 108.34 million shares outstanding. Atlantic Power Corporation is a component of the the S&P/TSX SmallCap Index.

February 22 was a positive day for Platinum Group Metals Ltd. (PTM:CA) as its stock finished the day having gained 6.57% to hit a price of $2.11 a share. The company reached a market cap of 69.2 million and has 32.8 million shares outstanding. Platinum Group Metals Ltd. is a component of the the S&P/TSX SmallCap Index.